Cubresa Inc

Our vision is to improve human well-being by empowering researchers to better understand complex diseases and develop personalized therapies. We develop and market PET nuclear imaging products to allow medical professionals at leading hospitals, universities and pharmaceutical companies to non-invasively visualize and measure biochemical processes at the molecular level. Applications for our products include preclinical drug development and disease research in oncology, neurological, and cardiovascular areas. Our multimodal preclinical in vivo imaging systems feature ultra-compact scanner footprints and excellent resolution, sensitivity and image quality

Molecular imaging,preclinical imaging,drug discovery,disease and therapeutic research,life science research,nuclear medicine,pet/mri,and simultaneous pet/mri imaging

Cubresa inc operates in the Biotechnology research industry.

Cubresa inc's revenue is 11m - 100m

Cubresa inc has 11 - 50 employees.